Equities

Qingdao Vland Biotech INC

603739:SHH

Qingdao Vland Biotech INC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)10.34
  • Today's Change-0.14 / -1.34%
  • Shares traded2.96m
  • 1 Year change-26.46%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue1,1991,1631,151
OPERATING EXPENSES
Cost of revenue total648663620
Selling, general and admin. expenses, total311303285
Depreciation/amortization362924
Unusual expense(income)4.441.241.59
Other operating expenses, total(21)(30)(38)
Total operating expense1,0761,060980
Operating income123103171
Other, net(0.15)(0.65)0.63
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes122102171
Provision for income taxes201721
Net income after taxes10385150
Minority interest(22)(16)(18)
Net income before extra. Items8170133
Total extraordinary items------
Net income8170133
Inc.avail. to common excl. extra. Items8170133
Inc.avail. to common incl. extra. Items8170133
EPS RECONCILIATION
Basic/primary weighted average shares252249246
Basic/primary eps excl. extra items0.320.280.54
Basic/primary eps incl. extra items0.320.280.54
Dilution adjustment------
Diluted weighted average shares252249246
Diluted eps excl. extra items0.320.280.54
Diluted eps incl. extra items0.320.280.54
COMMON STOCK DIVIDENDS
DPS - common stock primary issue0.100.100.16
Gross dividend - common stock252540
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental15122.12
SUPPLEMENTAL INCOME
Depreciation, supplemental655745
Total special items4.701.301.59
NORMALISED INCOME
Normalized income before taxes127103173
Effect of special items on income taxes0.750.210.20
Income tax excluding impact of special items201722
Normalized income after tax10786151
Normalized income avail. to common8571134
Basic normalized EPS0.340.280.55
Diluted normalized EPS0.340.280.55
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.